Form 4: Rani Therapeutics Holdings Executive Sells Shares
Insider Transaction (Form 4)
Alireza Javadi, Chief Technical Officer of Rani Therapeutics Holdings, Inc., sold 386 shares of common stock on March 27, 2026 for $0.78 per share.
Summary
- Open-market sale: disposed of 386 Class A Common Stock at $0.78 ($301) on March 27, 2026; holds 9,689 after (Direct).
- Tax/exercise-price withholding: disposed of 309 Class A Common Stock at $0.74 ($229) on June 27, 2026; holds 9,380 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $301 of stock on the open market.
Insider Transactions
Alireza Javadi — Officer (Chief Technical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-03-27 | Open-market sale | Class A Common Stock | 386 | $1 | $301 | 9,689 |
| 2026-06-27 | Tax/exercise-price withholding | Class A Common Stock | 309 | $1 | $229 | 9,380 |
Key Dates
| Date | Description |
|---|---|
| 2026-03-27 | Open-market sale (386 shares) |
| 2026-06-27 | Tax/exercise-price withholding (309 shares) |
Keywords
insider transaction, Form 4, RANI, Rani Therapeutics Holdings, Inc., bearish, Alireza Javadi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.